Defining ‘complementary and alternative medicine’ by Trethewey, Samuel P. et al.
CORRESPONDENCE
Defining ‘complementary and 
alternative medicine’
DISCUSSION
Samuel P. Trethewey
University Hospitals Birmingham 
NHS Foundation Trust
Julien Morlet
University Hospitals Birmingham 
NHS Foundation Trust
Christopher S. Trethewey
Leicester Cancer Research Centre 
University of Leicester
Ella K.M. Reynolds
Birmingham Women’s and Children’s 
NHS Foundation Trust 
Address for Correspondence:
Dr Samuel P. Trethewey
Birmingham Heartlands Hospital 
Birmingham, B9 5SS
Email: s-trethewey@doctors.org.uk
No conflicts of interest to declare 
Accepted for Publication:
12.11.2018
AUTHOR
The topic of complementary and alternative medicine (CAM) is 
controversial. CAM is a confusing term used to encapsulate a broad 
range of health-related practices. In this article we explore several 
CAM practices including homeopathy and manipulation therapies 
such as osteopathy and chiropractic. We examine the difficulty in 
understanding the meaning of the term CAM and argue that the term 
is unhelpful and should be avoided in the education of healthcare 
professionals. Medical educators should be careful to highlight the 
heterogeneity of health-related practices and treat each practice as an 
individual entity without the need for the umbrella term CAM.
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The topic of complementary and alternative medicine (CAM) is controversial. Debate 
surrounding CAM is largely driven by the unclear efficacy of many practices, a 
perceived potential risk of harm and a perception that financial motivations of CAM 
practitioners may influence their treatment recommendations. But what exactly is 
CAM? The term CAM is often used to describe a broad range of health-related 
practices which are thought to lie outside the realm of ‘conventional’ medicine. 
(1) In 2005, a national survey of the general population in England found that 
approximately 1 in 4 adults had used some form of CAM and around 1 in 8 adults 
had consulted a CAM practitioner during the previous 12 months. (2) Given the 
significant proportion of adults accessing CAM, it is important that healthcare 
professionals are able to discuss CAM with patients. To do this we must first have a 
clear understanding of what CAM is and its role, or lack of, in treating patients. 
There are many health-related practices typically described as CAM, including 
acupuncture, aromatherapy, manipulation therapies (osteopathy and chiropractic) 
and homeopathy. (1) Professional opinion of these practices is varied. For example, 
homeopathy draws extensive criticism due to the pseudoscientific concepts 
underpinning it and the weak evidence of efficacy. (3-5) In the UK, Chief Medical 
Officer Dame Sally Davies and Chief Scientific Advisor Sir Mark Walport have both 
made their opinions of homeopathy clear, describing homeopathy as “rubbish” and 
“nonsense” respectively. (6,7) Osteopathy and chiropractic, on the other hand, are 
both regulated at a government level, and the National Institute for Health and Care 
Excellence (NICE) recommends manual therapy (including spinal manipulation, 
mobilisation and soft tissue massage) for the management of low back pain. (8) The 
clear heterogeneity of these practices raises the question of whether it is appropriate to 
group them together under the umbrella term ‘CAM’. Evidence suggests that certain 
treatments offered by chiropractors and osteopaths can be useful for the treatment 
of low back pain, (8) therefore surely these treatments can simply be defined as 
‘medicine’? 
The National Center for Complementary and Integrative Health (NCCIH) makes 
a distinction between the terms ‘complementary’ and ‘alternative’. (1) They state 
that “if a non-mainstream practice is used together with conventional medicine, it’s considered 
‘complementary’” and “if a non-mainstream practice is used in place of conventional medicine, 
it’s considered ‘alternative’”. This distinction is also found on the Cancer Research 
UK website. (9) These definitions are vague and therefore open to interpretation. 
What is ‘mainstream’ or ‘conventional’ in one region of the world may be very 
different in another region. Assuming that for a health-related practice to become 
‘conventional’ in the UK it should have demonstrated efficacy in the face of rigorous 
scientific investigation, it could be suggested that ‘conventional’ has been substituted 
for ‘evidence-based’. One might therefore infer that ‘non-conventional’ has been 
substituted for ‘non-evidence based’. However, this relies heavily on the assumption 
that all ‘conventional ‘or ‘mainstream’ medicine in the UK is evidence-based. This 
may be an un-wise assumption to make given the shortfalls of the evidence-based 
medicine movement. In a BMJ editorial, Greenhalgh et al. described evidence-based 
medicine as “a movement in crisis” due to various factors including “evidence biases and 
the hidden hand of vested interests”. (10) Pharmaceutical companies play an important 
role in funding medical research, however the influence of pharmaceutical companies 
on healthcare practices and public health policy is a concern. (11) Examples of 
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financial conflicts of interest include consultant fees and honoraria related to new 
medicinal products or technologies. These conflicts of interest have the potential to 
influence medical research and individual clinical practice, undermining evidence-
based medicine. (12)
Despite randomised controlled trials (RCTs) being regarded as the highest level 
of evidence in the hierarchical ‘evidence pyramid’, they are not without their 
limitations. RCTs may produce misleading results due to various forms of statistical 
bias inherent in their design. RCTs may also not be representative of ‘real life’ 
patients in that participants may be highly selected in terms of characteristics such as 
age and comorbidity. It is also critical to differentiate between statistical and clinical 
significance. An RCT of a new treatment that shows a highly statistically significant 
difference in outcome, but a small treatment effect size, is unlikely to affect clinical 
practice. Publication bias also influences dissemination of evidence; a clinical trial 
which shows a statistically significant treatment benefit is more likely to be published 
than a ‘negative’ trial, despite the scientific value of both. (13) A notable proponent of 
evidence-based medicine, Ben Goldacre, recently published a study highlighting that 
over half of all clinical trials registered on the EU Clinical Trials Register (EUCTR) 
did not comply with the European Commission’s requirement that all trials must 
publish trial results to the EUCTR within 12 months of completion. (14) Despite 
the delays in publishing clinical trial data, the volume of new evidence published 
daily in peer-reviewed journals is overwhelming. (15) As clinicians, we therefore rely 
on reputable organisations such as NICE and other national societies to evaluate the 
evidence-base for a particular treatment and provide guidance on how this treatment 
should or should not be integrated into clinical practice. Complicating the matter 
further, the assessment of evidence performed by NICE (in the context of the ‘free at 
the point of delivery’ healthcare system that is the NHS) considers treatment cost and 
the relative benefit in terms of quality of life years (QALY) gained. Whilst critiquing 
the strength of evidence for CAM, it is important to keep in mind the shortcomings 
that exist even within mainstream, ‘evidence-based’ medicine. 
A further issue with the term CAM is that defining something as an ‘alternative 
medicine’ implies that it is indeed a ‘medicine’, and therefore has proven efficacy 
above and beyond the placebo effect. Given the weak evidence base of many CAM 
practices, (16) the use of the term ‘medicine’ may be misleading for patients and 
healthcare professionals.  It could be argued that the potential placebo effect conferred 
by a treatment of unclear efficacy may warrant the use of the term ‘medicine’. (17) 
However, this is problematic, as we would therefore have to accept that any health-
related practice intended to treat, or perceived to have efficacy by the patient,’ is 
‘medicine’. This seems unsatisfactory and contradicts the mantra of evidence-based 
medicine.
An essential component of undergraduate medical education is teaching medical 
students to critically appraise literature to determine the evidence-base for treatments 
and guide clinical practice. However, teaching of the evidence-base of health-related 
practices that are currently described as CAM may be subject to several barriers. For 
example, medical educators may dismiss certain treatments due to personal biases, 
inadequate understanding of the evidence-base or a perception that teaching about 
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specific treatments gives these treatments ‘undeserved credibility’. (18) The contrary 
can be true, teaching medical students about pseudoscience is important and may  
improve their ability to identify health-related practices with weak evidence bases. By 
confronting specific health-related practices and examining the evidence, educators 
can help to ‘dispel pseudoscience and promote scientific scepticism, while avoiding 
the unhealthy extremes of either uncritical acceptance or cynicism.’ (19) 
In conclusion, the ambiguity of the term CAM is unhelpful and oversimplifies a 
highly heterogeneous group of health-related practices with significantly different 
evidence bases.  There is a risk that these practices are perceived by healthcare 
professionals as having a shared illegitimacy. As a result, evidence-based treatments 
may be dismissed or underutilised. Every health-related practice should be treated 
as an individual entity and evaluated as such, without the need for a blanket term. 
Medical educators should be careful to highlight the heterogeneity of health-related 
practices and avoid using the term CAM in the teaching of healthcare professionals.
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